A detailed history of Jennison Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jennison Associates LLC holds 17,276,282 shares of AZN stock, worth $1.35 Billion. This represents 0.79% of its overall portfolio holdings.

Number of Shares
17,276,282
Previous 17,732,542 2.57%
Holding current value
$1.35 Billion
Previous $1.19 Billion 1.99%
% of portfolio
0.79%
Previous 0.9%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$61.03 - $69.57 $27.8 Million - $31.7 Million
-456,260 Reduced 2.57%
17,276,282 $1.17 Billion
Q4 2023

Feb 01, 2024

SELL
$61.89 - $69.28 $323 Million - $361 Million
-5,213,962 Reduced 22.72%
17,732,542 $1.19 Billion
Q3 2023

Oct 31, 2023

BUY
$64.85 - $71.7 $73.9 Million - $81.7 Million
1,139,295 Added 5.22%
22,946,504 $1.55 Billion
Q2 2023

Aug 03, 2023

BUY
$69.91 - $75.81 $393 Million - $426 Million
5,617,054 Added 34.69%
21,807,209 $1.56 Billion
Q1 2023

Apr 26, 2023

BUY
$63.15 - $71.6 $688 Million - $780 Million
10,895,302 Added 205.77%
16,190,155 $1.12 Billion
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $46.3 Million - $60.1 Million
853,190 Added 19.21%
5,294,853 $359 Million
Q3 2022

Nov 01, 2022

BUY
$53.02 - $135.75 $17.3 Million - $44.3 Million
326,337 Added 7.93%
4,441,663 $244 Million
Q2 2022

Aug 02, 2022

BUY
$59.26 - $71.14 $27.1 Million - $32.6 Million
457,836 Added 12.52%
4,115,326 $272 Million
Q1 2022

May 11, 2022

BUY
$55.72 - $67.12 $46.7 Million - $56.2 Million
837,575 Added 29.7%
3,657,490 $243 Million
Q4 2021

Feb 08, 2022

SELL
$54.02 - $63.83 $12.4 Million - $14.6 Million
-228,903 Reduced 7.51%
2,819,915 $164 Million
Q3 2021

Nov 09, 2021

SELL
$55.56 - $60.79 $1,166 - $1,276
-21 Reduced -0.0%
3,048,818 $183 Million
Q2 2021

Aug 12, 2021

BUY
$48.42 - $60.18 $5.65 Million - $7.02 Million
116,660 Added 3.98%
3,048,839 $183 Million
Q1 2021

May 11, 2021

SELL
$47.16 - $54.44 $330 Million - $381 Million
-6,993,091 Reduced 70.46%
2,932,179 $146 Million
Q4 2020

Feb 05, 2021

SELL
$48.52 - $58.02 $1.02 Billion - $1.22 Billion
-21,110,188 Reduced 68.02%
9,925,270 $496 Million
Q3 2020

Nov 04, 2020

SELL
$53.07 - $61.1 $430 Million - $495 Million
-8,098,278 Reduced 20.69%
31,035,458 $1.7 Billion
Q2 2020

Aug 06, 2020

BUY
$43.1 - $55.31 $14.3 Million - $18.3 Million
331,613 Added 0.85%
39,133,736 $2.07 Billion
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $81.2 Million - $110 Million
2,148,165 Added 5.86%
38,802,123 $1.73 Billion
Q4 2019

Feb 07, 2020

BUY
$42.46 - $50.46 $28.4 Million - $33.8 Million
669,273 Added 1.86%
36,653,958 $1.83 Billion
Q3 2019

Nov 08, 2019

BUY
$40.12 - $45.47 $84.1 Million - $95.3 Million
2,096,600 Added 6.19%
35,984,685 $1.6 Billion
Q2 2019

Aug 06, 2019

SELL
$37.28 - $41.68 $357 Million - $399 Million
-9,574,056 Reduced 22.03%
33,888,085 $0
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $82.9 Million - $100 Million
-2,334,646 Reduced 5.1%
43,462,141 $1.76 Billion
Q4 2018

Feb 06, 2019

BUY
$36.86 - $41.49 $223 Million - $251 Million
6,052,483 Added 15.23%
45,796,787 $1.74 Billion
Q3 2018

Nov 08, 2018

BUY
$34.76 - $39.72 $712 Million - $813 Million
20,470,137 Added 106.21%
39,744,304 $1.57 Billion
Q2 2018

Aug 02, 2018

BUY
$34.55 - $37.05 $666 Million - $714 Million
19,274,167 New
19,274,167 $677 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.